Virtual A2 Study for At Risk Children

Description

The goal of this behavioral-interventional study is to learn if the Abecedarian Approach implemented virtually for children ages 0-5 with a history of Hypoxic Ischaemic Encephalopathy (HIE) and/or premature birth produces the same effects as when administered at in-person facilities.

Conditions

Hypoxic Ischaemic Encephalopathy (HIE), Premature Birth, Cerebral Palsy, Neurological Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this behavioral-interventional study is to learn if the Abecedarian Approach implemented virtually for children ages 0-5 with a history of Hypoxic Ischaemic Encephalopathy (HIE) and/or premature birth produces the same effects as when administered at in-person facilities.

Virtual Abecedarian Approach (A2) For IPNH-NDCP (Infants With Perinatal Neurological Histories - At Risk for Neurodevelopmental Disabilities or Cerebral Palsy)

Virtual A2 Study for At Risk Children

Condition
Hypoxic Ischaemic Encephalopathy (HIE)
Intervention / Treatment

-

Contacts and Locations

Madison

University of Wisconsin Madison, Madison, Wisconsin, United States, 53715

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. IPNH-NDCP patients, including:
  • * Term-born children diagnosed during the neonatal period with hypoxic-ischemic encephalopathy, or
  • * premature children (born at less than 28 weeks gestational age).
  • 2. Parent or legal guardian will also be enrolled as a participant
  • 3. Parents must be English-speaking (able to provide consent and complete questionnaires).
  • 1. Not suitable for study participation due to other reasons at the discretion of the investigator.
  • 2. Infants with chromosomal abnormalities, genetic syndromes (for example, such as Down Syndrome or Trisomy18) and major congenital malformations will be excluded.
  • 3. Infants with vision impairment will also be excluded from the study, as our study procedures do require intact vision to be able to complete.
  • 4. For parents or legal guardians, there are no exclusion criteria.

Ages Eligible for Study

to 5 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Wisconsin, Madison,

Melisa Carrasco McCaul, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

2030-03